 The overall goal of this study is to open up the promising treatment of repetitive transcranial magnetic stimulation rTMS, which has been shown to be effective against seizures in patients with surface neocortical foci, to a much larger population of patients with mesial temporal lobe epilepsy MTLE and other forms of epilepsy with deep foci, who are not currently considered good rTMS candidates. 